Dobbs V. Wyeth: Are We There Yet, And At What Cost?
The battle over preemption of state law failure-to-warn claims involving pharmaceuticals bearing U.S. Food and Drug Administration-approved warnings has been waged for more than a decade. It continues with efforts to...To view the full article, register now.
Already a subscriber? Click here to view full article